PCZL represented Sela2, Inc., d/b/a Skila, in its June 2011 acquisition by Belhealth Investment Partners, Inc.  Skila is a global technology and services company specializing in product launch lifecycle management and engagement and relationship management solutions for the healthcare industry. Belhealth is a private equity buyout fund founded in 2011 targeting investment opportunities exclusively in the healthcare industry.  Hadar Solomon and Francine Alfandary represented Skila in the transaction.